Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014118 (
endocarditis
)
15,629
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background:
Staphylococcus aureus (S. aureus)
, a leading cause of bacteremia and infective
endocarditis
, exploits the human coagulation system by using a wide range of specific virulence factors. However, the impact of these host-pathogen interactions on the outcome of patients with
Staphylococcus aureus
bacteremia (SAB) remains unclear.
Methods:
A total of 178 patients with
S. aureus
bacteremia were included and analyzed regarding bacterial factors (
coa
gene size,
vWbp, clfA, clfB, fnbA, fnbB, fib)
and clinical parameters. A stepwise multivariate Cox regression model and a Partitioning Around Medoids (PAM) cluster algorithm were used for statistical analysis.
Results:
Patients' risk factors for 28-day mortality were creatinine (OR 1.49,
p
< 0.001), age (OR 1.9,
p
< 0.002), fibrinogen (OR 0.44,
p
< 0.004), albumin (OR 0.63,
p
< 0.02),
hemoglobin
(OR 0.59,
p
< 0.03), and CRP (OR 1.72,
p
< 0.04). Five distinct bacterial clusters with different mortality rates were unveiled, whereof two showed a 2-fold increased mortality and an accumulation of specific coagulase gene sizes, 547-base pairs and 660-base pairs.
Conclusions:
Based on the data obtained in the present study an association of coagulase gene size and
fib
regarding 28-day mortality was observed in patients with
S. aureus
bloodstream infections. Further animal and prospective clinical studies are needed to confirm our preliminary findings.
...
PMID:Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With
Staphylococcus aureus
Bloodstream Infections. 3250 2
<< Previous
1
2
3
4